Chronic kidney disease and risk of mortality, cardiovascular events or end-stage renal disease in older patients with hypertension

References

• Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 80(12), 1258–1270 (2011).
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin–angiotensin system inhibition. Ann. Intern. Med. 136(8), 604–615 (2002).
   PubMedGoogle Scholar
• Rahman M, Ford CE, Cutler JA et al.; ALLHAT Collaborative Research Group. Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. Clin. J. Am. Soc. Nephrol. 7(6), 989–1002 (2012).
   PubMedGoogle Scholar
• Stevens LA, Schmid CH, Greene T et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am. J. Kidney Dis. 56(3), 486–495 (2010).
   PubMed Web of Science ®Google Scholar
• ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288, 2981–2997 (2002).
   PubMed Web of Science ®Google Scholar
• Rahman M, Pressel S, Davis BR et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med. 165(8), 936–946 (2005).
   PubMedGoogle Scholar
• Rahman M, Pressel S, Davis BR et al.; ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann. Intern. Med. 144(3), 172–180 (2006).
   PubMedGoogle Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl.), S1–266 (2002).
   PubMedGoogle Scholar
• Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 82(3), 270–277 (2012).
   PubMed Web of Science ®Google Scholar
• Rule AD, Amer H, Cornell LD et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann. Intern. Med. 152(9), 561–567 (2010).
   PubMed Web of Science ®Google Scholar
• Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N. Engl. J. Med. 334(1), 13–18 (1996).
   PubMed Web of Science ®Google Scholar
• Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41(6), 1341–1345 (2003).
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J. Am. Soc. Nephrol. 18(10), 2758–2765 (2007).
   PubMed Web of Science ®Google Scholar
• Agrawal V, Marinescu V, Agarwal M, McCullough PA. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat. Rev. Cardiol. 6(4), 301–311 (2009).
   PubMedGoogle Scholar
• Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat. Rev. Nephrol. 8(5), 301–306 (2012).
   PubMedGoogle Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351(13), 1296–1305 (2004).
   PubMed Web of Science ®Google Scholar
• Brook MO, Bottomley MJ, Mevada C et al. Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk. QJM 105(3), 247–255 (2012).
   PubMedGoogle Scholar
• Rognant N, Lemoine S, Laville M, Hadj-Aïssa A, Dubourg L. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients. Diabetes Care 34(6), 1320–1322 (2011).
   PubMedGoogle Scholar
• Schaeffner ES, van der Giet M, Gaedeke J et al. The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur. J. Epidemiol. 25(3), 203–210 (2010).
   PubMedGoogle Scholar
• Norris K, Bourgoigne J, Gassman J et al.; AASK Study Group. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am. J. Kidney Dis. 48(5), 739–751 (2006).
   PubMedGoogle Scholar